Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non–muscle-invasive bladder cancer?—An International Bladder Cancer Network project
- 1 October 2016
- journal article
- review article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 34 (10) , 452-459
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Individual risk assessment in bladder cancer patients based on a multi-marker panelJournal of Cancer Research and Clinical Oncology, 2012
- Cystoscopy Revisited as the Gold Standard for Detecting Bladder Cancer Recurrence: Diagnostic Review Bias in the Randomized, Prospective CEFUB TrialJournal of Urology, 2010
- Bladder Cancer Screening in a High Risk Asymptomatic Population Using a Point of Care Urine Based Protein Tumor MarkerJournal of Urology, 2009
- Non‐muscle‐invasive bladder cancer surveillance for which cystoscopy is partly replaced by microsatellite analysis of urine: a cost‐effective alternative?BJU International, 2009
- The predictive value of multi-targeted fluorescent in-situ hybridization in patients with history of bladder cancerUrologic Oncology: Seminars and Original Investigations, 2008
- Immunocytology in the Assessment of Patients with Asymptomatic MicrohaematuriaEuropean Urology, 2007
- UroVysion Compared with Cytology and Quantitative Cytology in the Surveillance of Non–Muscle-Invasive Bladder CancerEuropean Urology, 2007
- Reflex UroVysion Testing of Bladder Cancer Surveillance Patients With Equivocal or Negative Urine CytologyAmerican Journal of Clinical Pathology, 2007
- Urine Markers for Bladder Cancer Surveillance: A Systematic ReviewEuropean Urology, 2005
- Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analysesUrology, 2003